.Merck beats incomes expectations, raises purchases overview on sturdy need for leading drugs like Keytruda CNBCMerck & Co. (MRK US) Beats Income Forecasts as Keytruda Sales Increase BloombergMerck Sell: Pharma Titan Posts Tough Results, However Overview Tumbles Short Entrepreneur's Company DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats income as well as sales assumptions in the middle of Keytruda strong point, however delivers mixed full-year expectation MarketWatch.